Sekisui Chemical (Osaka) says it has agreed to acquire the diagnostics business of Genzyme (Cambridge, MA) for $265 million. Genzyme’s diagnosticsbusiness has annual sales of about $167 million and provides raw materials and enzymes for biochemical, diabetes, infectious disease, and immunological testing. The deal includes about 575 employees throughout six locations: Exton, PA; Framingham, MA; San Diego, CA; Charlottetown, PEI; Rüsselsheim, Germany; and West Malling, U.K. Genzyme and Sekisui subsidiary Sekisui Medical (Tokyo) have been partnerssince 1995 in the supply and distribution of biochemical diagnosticsand related raw materials in the U.S. and Europe. Sekisui says the acquisition gives it a stronger platform for growth outside Japan. Sekisui Medical develops, manufactures, and distributes diagnostics, medical devices, pharmaceuticals, and fine chemicals. It had annual sales of ￥36.3 billion ($391.6 million) for its fiscal year ended March 31, 2010.
展开▼
